Dr. Hongxia Zhou is a professor at the Center for Translational Sciences and in the Robert Stempel College of Public Health and Social Work at Florida International University. Dr. Zhou received Doctor’s degree of medicine from Freiburg University in Germany and completed postdoctoral training at the University of Massachusetts Medical College. She spent 10 years at Thomas Jefferson University where she established a core lab for creating transgenic and knockin rats. She moved to the University of Central Florida in 2016 and joined FIU in 2019. Her research is focused on the molecular mechanisms of neuron death in neurodegenerative diseases.
Neurodegeneration in ALS is partially reversible in a rat model. Using a tetracycline-inducible gene expression system, we examined the reversibility of neurodegeneration in an ALS model. We found that neurons are prevented from demise in paralyzed rats after the ALS-causing gene TDP-43 is stopped from further expression. Motor function is partially recovered in the rats due to functional compensation from survived neurons. As no effective treatment is currently available for ALS, our finding encourages all efforts to develop effective treatments for the disease.
Reactive astrocytes secrete neurotoxic factors such as LCN2 to promote neuron death in neurodegenerative diseases. Astrocytes often become reactive in neurodegenerative diseases and activated astrocytes are believed to produce toxicity on neurons. Using multidisciplinary approach, we identified that reactive astrocytes secrete lipocalin 2 (LCN2) as a potent mediator of astrocytic neurotoxicity. LCN2 is known to stimulate quiescent astrocytes and microglia to become reactive.
- Keywords: neurodegenerative diseases; amyotrophic lateral sclerosis; gene manipulation in rat model; neurochemistry; molecular biology
Scholarly & Creative Works
Other Scholarly Work
principal investigator on
- Study on Neurodegeneration using TDP-43 Transgenic Rats awarded by Neurological Disorders and Stroke 2019 - 2021
- TMEM20 and Neurodegeneration in Parkinson's Disease awarded by Neurological Disorders and Stroke 2020 - 2025
- Hongxia Zhou